Nayak Sanjay 4

4 · OCULAR THERAPEUTIX, INC · Filed May 28, 2026

AI-generated summary of this filing

Updated May 28, 2026

OCULAR THERAPEUTIX (OCUL) CSO Sanjay Nayak Sells 1,858 Shares

What Happened

Sanjay Nayak, Chief Strategy Officer of Ocular Therapeutix (OCUL), reported a sale of 1,858 shares of common stock on May 26, 2026. The weighted average sale price was $8.20 per share for a total proceeds of approximately $15,236. This was a sale (not a purchase) and appears to be a routine sell-to-cover tax withholding transaction tied to RSU vesting, not a discretionary market trade.

Key Details

Transaction type: Sale (S) on 2026-05-26; Form 4 filed 2026-05-28 (timely).
Shares sold: 1,858 at a weighted average price of $8.20; reported price range $8.1440–$8.2512 (multiple executions). Reporting person can provide a per-price breakdown on request (footnote F2).
Reason/footnote: Sale executed under a durable automatic sale instruction adopted Feb 21, 2024, to effect a sell-to-cover election to satisfy tax withholding for RSUs that vested May 22, 2026 (footnote F1). The filing states the sales were not a discretionary trade by the reporting person.
Shares owned after transaction: Not specified in the information provided in this summary.

Context

Sell-to-cover transactions are common when restricted stock units vest and are used to pay taxes; they do not necessarily indicate management sentiment about the company’s outlook. This was not an option exercise or a gift—just a tax-withholding sale tied to RSU vesting.

Form 4

Period: 2026-05-26

Chief Strategy Officer

Transactions

Footnotes (2)

[F1]Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.1440 to $8.2512, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Signature

/s/ Todd Anderman, Attorney-in-Fact for Sanjay Nayak|2026-05-28

1 file